Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AZD3759 |
| Trade Name | |
| Synonyms | AZD-3759|zorifertinib |
| Drug Descriptions |
AZD3759 inhibits EGFR, potentially resulting in decreased growth of EGFR-expressing tumors and is also able to fully penetrate the blood-brain barrier (PMID: 27928026, PMID: 29430654). |
| DrugClasses | EGFR Inhibitor (Pan) 63 |
| CAS Registry Number | 1626387-80-1 |
| NCIT ID | C118289 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AZD3759 | AZD3759 | 0 | 1 |
| AZD3759 + Osimertinib | AZD3759 Osimertinib | 0 | 0 |
| AZD3759 + Radiotherapy | AZD3759 Radiotherapy | 0 | 0 |